Regarding Terumo, agreed, I would have thought the new formulation would be of great interest but we don't know to what extent the pandemic has affected things - global travel restrictions, local restrictions and all the other knock on effects - especially on health and medical services which will be prioritizing Covid treatment. I am hopeful on the Terumo but cannot believe the pandemic would have not impeded things significantly.
Ann: Improved Propofol TPM Formulation Passes Toxicology Study, page-137
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 41422233 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 39672334 | 32 |
View Market Depth
| Last trade - 10.05am 19/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable